← All trials
NCT02735590
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 1, 2016
- Primary completion
- Sep 1, 2018
- Completion date
- —
- First posted
- —
- Last posted
- —
- Enrollment
- 3200
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- University of Cape TownLead sponsor
- University of WashingtonCollaborator
- South African Tuberculosis Vaccine Initiative (SATVI)Overall official - principal investigator
- University of Cape TownReponsible party - principal investigator
- Centre for the AIDS Programme of Research in South AfricaCollaborator
- University of LondonCollaborator
- Stellenbosch UniversityCollaborator
- Aurum InstituteCollaborator
- South African Tuberculosis Vaccine Initiative (SATVI)Collaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.